Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.770
+0.540 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.770
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Pyxis Oncology Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pyxis Oncology stock have an average target of 6.50, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 134.66% from the current stock price of 2.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 23, 2026.
Analyst Ratings
The average analyst rating for Pyxis Oncology stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +116.61% | May 23, 2026 |
| Wedbush | Wedbush | Buy Reiterates $6 | Buy | Reiterates | $6 | +116.61% | May 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $5 | Buy | Maintains | $5 | +80.51% | May 15, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $7 | Buy | Maintains | $7 | +152.71% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +152.71% | May 15, 2026 |
Financial Forecast
Revenue This Year
43.75K
from 13.86M
Decreased by -99.68%
Revenue Next Year
3.13M
from 43.75K
Increased by 7,042.86%
EPS This Year
-1.23
from -1.28
EPS Next Year
-1.24
from -1.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 350,000 | 25.0M | |
| Avg | 43,750 | 3.1M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -97.5% | 57,042.9% | |
| Avg | -99.7% | 7,042.9% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.99 | -0.78 | |
| Avg | -1.23 | -1.24 | |
| Low | -1.51 | -1.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.